Circulating thrombopoietin level in chronic immune thrombocytopenic purpura

Authors

  • SATORU KOSUGI,

    1. 1 The Second Department of Internal Medicine, Osaka University Medical School, 2 Department of Blood Transfusion, Osaka University Hospital, Suita, Osaka, and 3Kirin Brewery Co. Ltd, Pharmaceutical Research Laboratory, Maebashi, Gumma, Japan
    Search for more papers by this author
  • YOSHIYUKI KURATA,

    1. 1 The Second Department of Internal Medicine, Osaka University Medical School, 2 Department of Blood Transfusion, Osaka University Hospital, Suita, Osaka, and 3Kirin Brewery Co. Ltd, Pharmaceutical Research Laboratory, Maebashi, Gumma, Japan
    Search for more papers by this author
  • YOSHIAKI T OMIYAMA,

    1. 1 The Second Department of Internal Medicine, Osaka University Medical School, 2 Department of Blood Transfusion, Osaka University Hospital, Suita, Osaka, and 3Kirin Brewery Co. Ltd, Pharmaceutical Research Laboratory, Maebashi, Gumma, Japan
    Search for more papers by this author
  • TOMOYUKI T AHARA,

    1. 1 The Second Department of Internal Medicine, Osaka University Medical School, 2 Department of Blood Transfusion, Osaka University Hospital, Suita, Osaka, and 3Kirin Brewery Co. Ltd, Pharmaceutical Research Laboratory, Maebashi, Gumma, Japan
    Search for more papers by this author
  • TAKASHI KATO,

    1. 1 The Second Department of Internal Medicine, Osaka University Medical School, 2 Department of Blood Transfusion, Osaka University Hospital, Suita, Osaka, and 3Kirin Brewery Co. Ltd, Pharmaceutical Research Laboratory, Maebashi, Gumma, Japan
    Search for more papers by this author
  • SEIJI TADOKORO,

    1. 1 The Second Department of Internal Medicine, Osaka University Medical School, 2 Department of Blood Transfusion, Osaka University Hospital, Suita, Osaka, and 3Kirin Brewery Co. Ltd, Pharmaceutical Research Laboratory, Maebashi, Gumma, Japan
    Search for more papers by this author
  • MASAMICHI SHIRAGA,

    1. 1 The Second Department of Internal Medicine, Osaka University Medical School, 2 Department of Blood Transfusion, Osaka University Hospital, Suita, Osaka, and 3Kirin Brewery Co. Ltd, Pharmaceutical Research Laboratory, Maebashi, Gumma, Japan
    Search for more papers by this author
  • SHIGENORI H ONDA,

    1. 1 The Second Department of Internal Medicine, Osaka University Medical School, 2 Department of Blood Transfusion, Osaka University Hospital, Suita, Osaka, and 3Kirin Brewery Co. Ltd, Pharmaceutical Research Laboratory, Maebashi, Gumma, Japan
    Search for more papers by this author
  • YUZURU KANAKURA,

    1. 1 The Second Department of Internal Medicine, Osaka University Medical School, 2 Department of Blood Transfusion, Osaka University Hospital, Suita, Osaka, and 3Kirin Brewery Co. Ltd, Pharmaceutical Research Laboratory, Maebashi, Gumma, Japan
    Search for more papers by this author
  • YUJI MATSUZAWA

    1. 1 The Second Department of Internal Medicine, Osaka University Medical School, 2 Department of Blood Transfusion, Osaka University Hospital, Suita, Osaka, and 3Kirin Brewery Co. Ltd, Pharmaceutical Research Laboratory, Maebashi, Gumma, Japan
    Search for more papers by this author

Dr Yoshiyuki Kurata Department of Blood Transfusion, Osaka University Hospital, 2–15, Yamadaoka, Suita City, Osaka, Japan.

Abstract

The circulating thrombopoietin (TPO) level in 43 patients with chronic immune thrombocytopenic purpura (ITP) was examined by an ELISA system. The TPO level (mean±SD) in ITP patients was mildly elevated (1.86±1.17 fmol/ml) compared to that in normal subjects (0.76±0.21), and was within the normal range in 30% of ITP patients. In contrast, the TPO level in patients with aplastic anaemia was very high, 12.35±6.42 fmol/ml. There was no correlation between TPO level and platelet count in ITP patients. Splenectomy was performed in two ITP patients, after which platelet counts increased to normal levels and TPO levels showed a transient increase. These data suggest that reactive TPO production against thrombocytopenia in ITP is small when compared to that in aplastic anaemia. Relative endogenous TPO deficiency may play some role in the pathophysiology of thrombocytopenia in ITP patients.

Ancillary